Dazhou Liao

Construction of PANoptosis signature: Novel target discovery for prostate cancer immunotherapy

Xianyanling Yi, Jin Li, Xiaonan Zheng et al. · Molecular Therapy — Nucleic Acids · 2023 · 54 citations · Full text

Novel Target Discovery, Immunology, Pathology +18

IGFBP7 and the Tumor Immune Landscape: A Novel Target for Immunotherapy in Bladder Cancer

Xianyanling Yi, Xiaonan Zheng, Hang Xu et al. · Frontiers in Immunology · 2022 · 23 citations · Full text

Immunology, Immunoediting, Pathology +18

Sevoflurane activates hippocampal CA3 kainate receptors (Gluk2) to induce hyperactivity during induction and recovery in a mouse model

Peng Liang, F. Li, Jin Liu et al. · British Journal of Anaesthesia · 2017 · 21 citations · Full text

Neurophysiology, Medicine, Physiology +9

SR9009 inhibits lethal prostate cancer subtype 1 by regulating the LXRα/FOXM1 pathway independently of REV-ERBs

Hang Xu, Jiapeng Zhang, Xiaonan Zheng et al. · Cell Death and Disease · 2022 · 21 citations · Full text

Vinculin orchestrates prostate cancer progression by regulating tumor cell invasion, migration, and proliferation

Xiaonan Zheng, Hang Xu, Lina Gong et al. · The Prostate · 2021 · 18 citations